Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MOREWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MOREUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don’t find the answers you’re looking for, contact us for additional assistance.
EXPLORE MOREThis gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated.
Loading...
| CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | Inquiry & Datasheet |
| CAR-ZP8582 | Anti-WT1 (ESKM) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | ESKM | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8583 | Anti-WT1 (ESKM) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | ESKM | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8584 | Anti-WT1 (ESK1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | ESK1 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8585 | Anti-WT1 (ESK1) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | ESK1 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8586 | Anti-WT1 (Aali) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | Aali | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8587 | Anti-WT1 (Aali) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | Aali | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8588 | Anti-WT1 (DS3886AB) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | DS3886AB | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8589 | Anti-WT1 (DS3886AB) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | DS3886AB | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8590 | Anti-WT1 (7G-H3) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 7G-H3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8591 | Anti-WT1 (7G-H3) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 7G-H3 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8592 | Anti-WT1 (IHC685) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | IHC685 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8593 | Anti-WT1 (IHC685) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | IHC685 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8594 | Anti-WT1 (D8I7F) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | D8I7F | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8595 | Anti-WT1 (D8I7F) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | D8I7F | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8596 | Anti-WT1 (1E2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1E2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8597 | Anti-WT1 (1E2) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 1E2 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8614 | Anti-WT1 (D6M6S) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | D6M6S | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8615 | Anti-WT1 (D6M6S) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | D6M6S | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8616 | Anti-WT1 (CAN-R9(IHC)-56-2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CAN-R9(IHC)-56-2 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8617 | Anti-WT1 (CAN-R9(IHC)-56-2) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | CAN-R9(IHC)-56-2 | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8618 | Anti-WT1 (9F523) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 9F523 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8619 | Anti-WT1 (9F523) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 9F523 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8620 | Anti-WT1 (5H9-F12-E11-F6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 5H9-F12-E11-F6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8621 | Anti-WT1 (5H9-F12-E11-F6) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 5H9-F12-E11-F6 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8622 | Anti-WT1 (5G8-F5-E12) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 5G8-F5-E12 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8623 | Anti-WT1 (5G8-F5-E12) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 5G8-F5-E12 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8624 | Anti-WT1 (5G11A5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 5G11A5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8625 | Anti-WT1 (5G11A5) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 5G11A5 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8626 | Anti-WT1 (4H8-F11-E12) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 4H8-F11-E12 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8627 | Anti-WT1 (4H8-F11-E12) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 4H8-F11-E12 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8628 | Anti-WT1 (4H383) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 4H383 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8629 | Anti-WT1 (4H383) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 4H383 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8630 | Anti-WT1 (3B12) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3B12 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8631 | Anti-WT1 (3B12) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 3B12 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8632 | Anti-WT1 (2H4) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2H4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8633 | Anti-WT1 (2H4) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 2H4 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8634 | Anti-WT1 (1E9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1E9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8635 | Anti-WT1 (1E9) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 1E9 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8636 | Anti-WT1 (1A12) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1A12 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |
| CAR-ZP8637 | Anti-WT1 (1A12) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 1A12 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell |
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.
LEARN MORE
Angiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.
LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.
LEARN MORE
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE
